Journal section "Sectoral economic studies"

Determinants of Innovation Activity of Russian Pharmaceutical Manufacturers

Berkovich M.I., Volin A.Y.

Volume 15, Issue 6, 2022

Berkovich M.I., Volin A.Yu. (2022). Determinants of innovation activity of Russian pharmaceutical manufacturers. Economic and Social Changes: Facts, Trends, Forecast, 15(6), 110–123. DOI: 10.15838/esc.2022.6.84.6

DOI: 10.15838/esc.2022.6.84.6

Abstract   |   Authors   |   References
  1. Alam A., Uddin M., Yazdifar H. (2019). Citation: Institutional determinants of R&D investment: Evidence from emerging markets. Technological Forecasting and Social Change, Vol. 138, 34–44. DOI: 10.1016/j.techfore.2018.08.007
  2. Avdonina S.G. (2011). Innovation activity factors of enterprises. Ekonomicheskie nauki=Economic Sciences, 12(85), 33–36 (in Russian).
  3. Berkovich M.I., Volin A.Yu. (2021). On innovative activity in pharmaceutical industry. Vestnik NGUEU=Vestnik NSUEM, 2, 168–174. DOI: 10.34020/2073-6495-2021-2-168-174 (in Russian).
  4. Cohen W.M. (2010). Citation: Fifty years of empirical studies of innovative activity and performance. Handbook of the Economics of Innovation, 01, 131–213. DOI: 10.1016/S0169-7218(10)01004-X
  5. Davidson N., Mariev O., Pushkarev A. (2018). Regional factors in innovation activity of Russian enterprises. Forsait=Foresight, 12(3), 62–72. DOI: 10.17323/2500-2597.2018.3.62.72 (in Russian).
  6. Deangelis C. (2016). Big Pharma profits and the public loses. The Milbank Quarterly, 94(1), 30–33. DOI: 10.1111/1468-0009.12171
  7. DiMasi J.A., Grabowski H.G., Hansen R.W. (2016). Citation: Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20–33. DOI: 10.1016/j.jhealeco.2016.01.012
  8. Ding J., Xue Y., Liang H., Shao R., Chen Y. (2011). Citation: From imitation to innovation: A study of China’s drug R&D and relevant national policies. Journal of Technology Management & Innovation, 6(2). Available at: DOI: 10.4067/S0718-27242011000200001
  9. Dubrova T.A., Ermolina A.A. (2019). Innovative activity determinants of manufacturing enterprises in Russia. Drukerovskii vestnik=Drukerovskij Vestnik, 5, 79–89. DOI: 10.17213/2312-6469-2019-5-79-89 (in Russian).
  10. Evstratov A.V. (2018). Osnovnye tendentsii i perspektivy razvitiya farmatsevticheskogo rynka v Rossiiskoi Federatsii: monografiya [The Main Trends and Prospects for the Development of the Pharmaceutical Market in the Russian Federation: A Monograph]. Volgograd: VolgGTU.
  11. Gernego Yu.A., Dyba A.M., Petrenko L.A. (2019). Innovation activity determinants in the context of socio-economic growth. Financial and Credit Activity Problems of Theory and Practice, 445¬–453 (in Russian).
  12. Higon D.A., Driffield N. (2010). Citation: Exporting and innovation performance: Analysis of the annual Small Business Survey in the UK. International Small Business Journal, 29(1), 4–24. DOI: 10.1016/j.jhealeco.2016.01.012
  13. Ibatullova Yu.T. (2008). Innovation activity factors of business entities, their typology and cooperation. Vestnik ekonomiki, prava i sotsiologii=The Review of Economy, the Law and Sociology, 2, 10–14 (in Russian).
  14. Karakulina K.N. (2020). Factors defining innovative activation of industrial enterprises. Vestnik Akademii znanii=Bulletin of the Academy of Knowledge, 46(6), 151–159. DOI: 10.24412/2304-6139-2020-10780 (in Russian).
  15. Krammer S. (2009). Drivers of national innovation in transition: Evidence from a panel of Eastern European countries. Research Policy, 38(5), 845–860. DOI: 10.1016/j.respol.2009.01.022
  16. Kuznetsov I.A., Malitskaya V.B., Sukhova V.E., Ivanova A.V., Proskurina I.Yu. (2017). Citation: Innovation Activity of Russian Business Entities and its Determinants. European Research Studies Journal, XX (Issue 3B), 395–402. DOI: 10.35808/ersj/795
  17. Lambertini L., Orsini R. (2000). Citation: Process and product innovation in a vertically differentiated monopoly. Economic letters, 68(3), 333–337.
  18. Malik S. (2020). Citation: Macroeconomic determinants of innovation: Evidence from Asian countries. Global Business Review. Available at: DOI: 10.1177/0972150919885494
  19. Ornaghi C. (2009). Mergers and innovation in big pharma. International Journal of Industrial Organization, 27(1), 70–79.
  20. Panyavina E.A., Vanyatinskii F.V. (2012). Factors of development of innovative activity of enterprise structures. Sotsial’no-ekonomicheskie yavleniya i protsessy=Social-Economic Phenomena and Processes, 12(046), 252–255 (in Russian).
  21. Razumova I.A., Pokrovskaya, N.N., Akhmerova L.V. (2017). Composition of innovative activity parameters for a system of analysis and making decision in the innovations. Upravlencheskoe konsul’tirovanie=Administrative Consulting, 10, 59–72. DOI: 10.22394/1726-1139-2017-10-59-72 (in Russian).
  22. Szmelter A. (2018). Citation: Global Supply Chains in the Pharmaceutical Industry. Gdańsk: University of Gdańsk.
  23. Tipanov V.V. (2014). Trends of innovative activity in the world pharmaceutical market. Vektor nauki Tol’yattinskogo gosudarstvennogo universiteta. Seriya: Ekonomika i upravlenie=Science Vector of Togliatti State University. Series: Economics and Management, 1(16), 85–89 (in Russian).
  24. Zabolotskii S.A., Markov L.S. (2010). Innovative activity of enterprises in the domestic chemical industry. EKO=ECO, 3(429), 64–75 (in Russian).
  25. Zakic N., Jovanovic A., Stamatovic M. (2008). Citation: External and internal factors affecting the product and business process innovation. Economics and Organization, 1(5), 17–29.

Article views

all: , this year: , this month: , today:

Article downloads

all: , this year: , this month: , today:

View full article